Stay updated on Durvalumab & Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelimumab in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s footer has updated the ClinicalTrials.gov interface revision/version from v3.5.2 to v3.5.3. This reflects a platform update rather than a change to the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-24T16:52:39.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:43:35.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Napoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the study locations.
    Difference
    0.0%
    Check dated 2026-03-27T02:14:43.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision metadata updated: added Revision: v3.5.0 and removed Revision: v3.4.3. No study details or participant information are affected.
    Difference
    0.0%
    Check dated 2026-03-19T23:42:05.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a minor technical update with no changes to study content or functionality.
    Difference
    0.0%
    Check dated 2026-03-12T20:23:46.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed. This is a minor version/metadata update that does not affect the study content or the page’s primary functions.
    Difference
    0.0%
    Check dated 2026-02-12T01:54:39.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelimumab in NSCLC Clinical Trial page.